NASDAQ · Price History

MapLight Therapeutics, Inc. (MPLT) Stock Price History & Returns

$6.57 NASDAQ: MPLT Market Cap $280.00M

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How MapLight Therapeutics, Inc. (MPLT) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $6.57 sits 1% of the way up a 52-week range of $6.06 to $40.43; 83.7% below the 52-week high; below its 50-day moving average of $9.34; below its 200-day average of $19.96; a beta of 3.01 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-41.6%
6 months-75.2%
1 year-51.0%

Year by year

0 of 1 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$6.57-62.6%

Monthly closing prices

The last 14 months, newest first. 5 of 13 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$6.57-13.3%
October 2026$7.58-25.6%
September 2026$10.19-21.4%
August 2026$12.97-0.4%
July 2026$13.02-63.7%
June 2026$35.84+22.3%
May 2026$29.31-8.0%
April 2026$31.87+56.8%
March 2026$20.33+17.7%
February 2026$17.27-2.4%
January 2026$17.69+0.7%
December 2025$17.57+28.9%
November 2025$13.63-19.4%
October 2025$16.92—

MapLight Therapeutics, Inc. (MPLT) price history — frequently asked questions

How has MapLight Therapeutics, Inc. performed over the last year?

MapLight Therapeutics, Inc. (MPLT) has fallen 51.0% over the last twelve months, measured on price alone.

What is MapLight Therapeutics, Inc.'s five-year return?

Over five years the MPLT share price has gained 0.0%, excluding dividends.

What is MapLight Therapeutics, Inc.'s 52-week range?

Over the last year MapLight Therapeutics, Inc. (MPLT) has traded between $6.06 and $40.43.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.